Bausch Lomb runs it back with dealmaker Saunders as CEO - FiercePharma
| REG Stock | 6.21 0.05 0.80% |
Slightly above 62% of Regis Healthcare's investor base is looking to short. The analysis of overall sentiment of trading Regis Healthcare stock suggests that many investors are alarmed at this time. Regis Healthcare's investing sentiment can be driven by a variety of factors including economic data, Regis Healthcare's earnings reports, geopolitical events, and overall market trends.
Regis |
Bausch Lomb runs it back with dealmaker Saunders as CEO FiercePharma
Read at news.google.com
 |
Regis Healthcare Fundamental Analysis
We analyze Regis Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Regis Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Regis Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Regis Healthcare is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Regis Healthcare Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Regis Healthcare stock to make a market-neutral strategy. Peer analysis of Regis Healthcare could also be used in its relative valuation, which is a method of valuing Regis Healthcare by comparing valuation metrics with similar companies.
Peers
Regis Healthcare Related Equities
| CBAPJ | Commonwealth Bank | 0.63 | ||||
| CBA | Commonwealth Bank | 0.28 | ||||
| CBAPK | Commonwealth Bank | 0.14 | ||||
| CBAPG | Commonwealth Bank | 0.02 | ||||
| WBCPI | Westpac Banking | 0.00 | ||||
| ATM | Aneka Tambang | 0.00 | ||||
| CBAPH | Commonwealth Bank | 0.00 | ||||
| BHP | BHP Group | 0.43 |
Additional Tools for Regis Stock Analysis
When running Regis Healthcare's price analysis, check to measure Regis Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regis Healthcare is operating at the current time. Most of Regis Healthcare's value examination focuses on studying past and present price action to predict the probability of Regis Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regis Healthcare's price. Additionally, you may evaluate how the addition of Regis Healthcare to your portfolios can decrease your overall portfolio volatility.